INTS Company Profile and Key Details

NASDAQ : INTS

Intensity Therapeutics

$5.21

0.0069+0.13%

At Close 4:00 PM

60.4

ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Intensity Therapeutics, Inc. (INTS) stock surged +0.13%, trading at $5.21 on NASDAQ, up from the previous close of $5.20. The stock opened at $5.21, fluctuating between $5.06 and $5.34 in the recent session.

Stock Snapshot

5.2

Prev. Close

9.82M

Market Cap

5.06

Day Low

-0.61

P/E Ratio

-8.56

EPS (TTM)

-0.53

Cash Flow per Share

5.21

Open

1.89M

Number of Shares

5.34

Day High

53.88%

Free Float in %

0.96

Book Value

40.18K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 05, 2026	5.21	5.34	5.06	5.21	40.21K
May 04, 2026	5.18	5.35	5.18	5.20	25.88K
Apr 30, 2026	5.26	5.27	4.98	5.21	46.65K
Apr 29, 2026	5.11	5.21	5.06	5.15	32.68K
Apr 28, 2026	5.23	5.28	5.15	5.17	18.66K
Apr 27, 2026	5.27	5.35	5.16	5.23	41.48K
Apr 23, 2026	5.21	5.39	5.15	5.33	37.19K
Apr 22, 2026	5.29	5.29	5.18	5.23	22.82K
Apr 21, 2026	5.35	5.35	5.15	5.19	16.78K
Apr 20, 2026	5.32	5.32	5.00	5.22	46.62K
Apr 17, 2026	5.21	5.42	5.20	5.30	59.67K
Apr 16, 2026	5.33	5.46	5.29	5.32	29.83K
Apr 14, 2026	5.55	5.55	5.25	5.36	25.71K
Apr 13, 2026	5.21	5.62	5.14	5.46	21.21K
Apr 10, 2026	5.49	5.70	5.30	5.50	15.17K
Apr 09, 2026	5.63	5.75	5.51	5.60	9.08K
Apr 08, 2026	5.25	5.52	5.11	5.50	36.13K
Apr 07, 2026	5.42	5.42	5.08	5.25	37.01K
Apr 06, 2026	5.80	5.80	5.41	5.49	39.95K
Apr 02, 2026	5.83	5.83	5.65	5.70	23.86K

Contact Details

Westport, CT 06880

United States

https://www.intensitytherapeutics.com 203 221 7381

About Company

Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. The company's lead product candidate is INT230-6, which is in Phase 2 clinical trial for the treatment of refractory solid tumors; and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. It has a collaboration agreement with Merck Sharpe & Dohme Corp. to evaluate the combination of INT230-6 and Keytruda in patients with advanced pancreatic, colon, squamous cell, and bile duct malignancies; Bristol-Myers Squibb Company to evaluate the combination of INT230-6 with Yervoy in patients with advanced liver, breast, and sarcoma cancers; and Ottawa Hospital Research Institute and the Ontario Institute of Cancer Research to study INT230-6 in a randomized controlled neoadjuvant phase II study in women with early-stage breast cancer. The company was founded in 2012 and is headquartered in Westport, Connecticut.

Stock Peers

ARGX

-16.39-2.02%

argenx SE$794.70 REGN

-6.94-0.98%

Regeneron Pharmaceuticals, Inc.$702.27 UTHR

-9.02-1.55%

United Therapeutics Corporation$572.20 MDGL

-16.19-3.12%

Madrigal Pharmaceuticals, Inc.$502.47 VRTX

-5.49-1.28%

Vertex Pharmaceuticals Incorporated$424.36 PRAX

-4.31-1.28%

Praxis Precision Medicines, Inc.$333.30 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

3.185+1.07%

Alnylam Pharmaceuticals, Inc.$301.11 KRYS

-2.38-0.83%

Krystal Biotech, Inc.$284.57 LGND

3.94+1.73%

Ligand Pharmaceuticals Incorporated$232.30

Frequently Asked Questions

What is the current Intensity Therapeutics, Inc. (INTS) stock price?

Intensity Therapeutics, Inc. (NASDAQ: INTS) stock price is $5.21 in the last trading session. During the trading session, INTS stock reached the peak price of $5.34 while $5.06 was the lowest point it dropped to. The percentage change in INTS stock occurred in the recent session was 0.13% while the dollar amount for the price change in INTS stock was $0.01.

INTS's industry and sector of operation?

The NASDAQ listed INTS is part of Biotechnology industry that operates in the broader Healthcare sector. Intensity Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of INTS?

No Data

How INTS did perform over past 52-week?

INTS's closing price is 12.58% higher than its 52-week low of $4.63 where as its distance from 52-week high of $43.50 is -88.03%.

How many employees does INTS have?

Number of INTS employees currently stands at 5.

Link for INTS official website?

Official Website of INTS is: https://www.intensitytherapeutics.com

How do I contact INTS?

INTS could be contacted at phone 203 221 7381 and can also be accessed through its website. INTS operates from 61 Wilton Road, Westport, CT 06880, United States.

How many shares of INTS are traded daily?

INTS stock volume for the day was 40.18K shares. The average number of INTS shares traded daily for last 3 months was 47.38K.

What is the market cap of INTS currently?

The market value of INTS currently stands at $9.82M with its latest stock price at $5.21 and 1.89M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	5
Beta	4.23
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	5
Beta	4.23
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

INTS Company Profile and Key Details

Intensity Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook